Table 3

Anticipated effects of substitution of whey protein for placebo on glucose parameters during continuous glucose monitoring (CGM) for patients who belong to the first quartile (clear cells) and third quartile (shaded cells) of body mass index (BMI), triglycerides and glucagon-like peptide (GLP)

Quartiles of baseline variablesAnticipated changes in CGM glucose parameters (mmol/L)
BMI (kg/m2)Triglyceride (mmol/L)GLP-1 (pmol/L)SleepEveningAverage
28.031.0514.39−0.75−1.32−0.92
28.031.0542.85−0.11−0.72−0.57
28.032.1314.39−0.40−0.62−0.38
28.032.1342.850.24−0.01−0.5
37.001.0514.390.73−1.12−0.03
37.001.0542.851.37−0.060.02
37.002.1314.391.08−0.450.22
37.002.1342.851.710.160.57